These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25645901)

  • 1. Efficacy of certolizumab pegol: a case study in a patient with rheumatoid arthritis on maintenance hemodialysis.
    Nishimura A; Minegishi Y; Kwamura K; Ichino A; Uchiyama K
    Rheumatol Int; 2015 Sep; 35(9):1601-2. PubMed ID: 25645901
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute exacerbation of rheumatoid interstitial lung disease during the maintenance therapy with certolizumab pegol.
    Migita K; Tsuji Y; Hisatomi K; Shigeno R; Izumi Y; Iwanaga N; Koga T
    Mod Rheumatol; 2017 Nov; 27(6):1079-1082. PubMed ID: 26044288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous leishmaniasis mimicking dactylitis in a patient with rheumatoid arthritis treated with certolizumab.
    Herrerias-Moreno J; Expósito-Serrano V; Agut-Busquet E; Corbacho M; Sáez E; Luelmo J
    Clin Exp Dermatol; 2018 Apr; 43(3):348-350. PubMed ID: 29218754
    [No Abstract]   [Full Text] [Related]  

  • 4. Certolizumab pegol was effective for treating residual synovitis after total knee arthroplasty in a patient with rheumatoid arthritis: therapeutic monitoring by ultrasound.
    Kawashiri SY; Michitsuji T; Kawakami A
    J Med Ultrason (2001); 2018 Apr; 45(2):371-374. PubMed ID: 28725981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Case of Minimal Change Disease in a Patient with Rheumatoid Arthritis Treated with Certolizumab.
    Hwang SR; Sawatsky AP
    J Rheumatol; 2019 Dec; 46(12):1647. PubMed ID: 31676702
    [No Abstract]   [Full Text] [Related]  

  • 6. Certolizumab Pegol: A Review in Inflammatory Autoimmune Diseases.
    Deeks ED
    BioDrugs; 2016 Dec; 30(6):607-617. PubMed ID: 27704400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between certolizumab pegol serum levels, anti-drug antibodies and treatment response in patients with inflammatory joint diseases: data from the NOR-DMARD study.
    Gehin JE; Goll GL; Warren DJ; Syversen SW; Sexton J; Strand EK; Kvien TK; Bolstad N; Lie E
    Arthritis Res Ther; 2019 Nov; 21(1):256. PubMed ID: 31783773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Miller Fisher syndrome following treatment with certolizumab in a patient with rheumatoid arthritis].
    Alberola-Amores FJ; Navarro-Canto L; Gonzalez-Ferrandez JA
    Rev Neurol; 2017 Sep; 65(6):286-288. PubMed ID: 28896005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling of the clinical and economic impact of a risk-sharing agreement supporting a treat-to-target strategy in the management of patients with rheumatoid arthritis in France.
    Fagnani F; Pham T; Claudepierre P; Berenbaum F; De Chalus T; Saadoun C; Joubert JM; Fautrel B
    J Med Econ; 2016 Aug; 19(8):812-21. PubMed ID: 27065315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Certolizumab pegol plus methotrexate 5-year results from the rheumatoid arthritis prevention of structural damage (RAPID) 2 randomized controlled trial and long-term extension in rheumatoid arthritis patients.
    Smolen JS; van Vollenhoven R; Kavanaugh A; Strand V; Vencovsky J; Schiff M; Landewé R; Haraoui B; Arendt C; Mountian I; Carter D; van der Heijde D
    Arthritis Res Ther; 2015 Sep; 17(1):245. PubMed ID: 26353833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twenty-eight-week results from the REALISTIC phase IIIb randomized trial: efficacy, safety and predictability of response to certolizumab pegol in a diverse rheumatoid arthritis population.
    Weinblatt ME; Fleischmann R; van Vollenhoven RF; Emery P; Huizinga TW; Cutolo M; van der Heijde D; Duncan B; Davies O; Luijtens K; Dougados M
    Arthritis Res Ther; 2015 Nov; 17():325. PubMed ID: 26568428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anaphylactic reaction by certolizumab in young woman with rheumatoid arthritis].
    Caballero-Requejo C; Monteagudo-González L; Urbieta-Sanz E
    Farm Hosp; 2018 May; 42(3):135-136. PubMed ID: 29730985
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of certolizumab pegol on patient-reported outcomes in rheumatoid arthritis and correlation with clinical measures of disease activity.
    Pope J; Bingham CO; Fleischmann RM; Dougados M; Massarotti EM; Wollenhaupt J; Duncan B; Coteur G; Weinblatt ME
    Arthritis Res Ther; 2015 Nov; 17():343. PubMed ID: 26614481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvements in productivity and increased participation in daily activities over 52 weeks of certolizumab pegol treatment of rheumatoid arthritis: results of a Belgian observational study.
    Westhovens R; Ravelingien I; Vandevyvere K; Pansar I; Purcaru O; Kumke T; Gyselbrecht L
    Acta Clin Belg; 2019 Oct; 74(5):342-350. PubMed ID: 30160189
    [No Abstract]   [Full Text] [Related]  

  • 15. Darier's disease and rheumatoid arthritis: a new association and a review of the literature.
    Pignataro F; Marigliano B; Sambataro G; Afeltra A
    Int J Rheum Dis; 2017 Dec; 20(12):2146-2147. PubMed ID: 26990674
    [No Abstract]   [Full Text] [Related]  

  • 16. New Approaches in Tumor Necrosis Factor Antagonism for the Treatment of Psoriatic Arthritis: Certolizumab Pegol.
    Cauli A; Piga M; Lubrano E; Marchesoni A; Floris A; Mathieu A
    J Rheumatol Suppl; 2015 Nov; 93():70-2. PubMed ID: 26523062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and survival-on-drug of certolizumab pegol in rheumatoid arthritis in clinical practice: results from the national Swedish register.
    Chatzidionysiou K; Kristensen LE; Eriksson J; Askling J; van Vollenhoven R;
    Scand J Rheumatol; 2015; 44(6):431-7. PubMed ID: 26084325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-hoc analysis showing better clinical response with the loading dose of certolizumab pegol in Japanese patients with active rheumatoid arthritis.
    Takeuchi T; Yamamoto K; Yamanaka H; Ishiguro N; Tanaka Y; Eguchi K; Watanabe A; Origasa H; Kobayashi M; Shoji T; Togo O; Miyasaka N; Koike T
    Mod Rheumatol; 2016 Jul; 26(4):473-80. PubMed ID: 26472043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of certolizumab pegol in rheumatoid arthritis: meeting rheumatologists' requirements in routine clinical practice.
    Punzi L; Lapadula G; Mathieu A
    BioDrugs; 2014 Apr; 28 Suppl 1():S25-37. PubMed ID: 24687236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Randomized Trial Comparing Disease Activity Measures for the Assessment and Prediction of Response in Rheumatoid Arthritis Patients Initiating Certolizumab Pegol.
    Curtis JR; Churchill M; Kivitz A; Samad A; Gauer L; Gervitz L; Koetse W; Melin J; Yazici Y
    Arthritis Rheumatol; 2015 Dec; 67(12):3104-12. PubMed ID: 26316013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.